In line with this, our independent immunohistochemistry on biopsies from patients suffering from minimal change disease, FSGS, membranous nephropathy, and pauci-immune crescentic nephritis showed an apparent downregulation of ARMH4 immunoreactivity. Here, ARMH4 is linked to focal segmental glomerulosclerosis.